About

Developing innovative therapeutics for human health.

BioStrategies LC specializes in the development of novel therapeutics for the treatment of Rare Diseases. To this purpose, BSLC has received multiple grant awards from NIH and other federal and state agencies to support its innovative research program.

BioStrategies continues to bring novel technologies to therapeutics for rare disease with the development of new lectin-based protein delivery systems. The company’s lectin-fusion proteins are designed to increase drug effectiveness by enhancing delivery to cells and tissues of the body that are not treated adequately by existing technologies.